Generics News
Czech Republic-based Zentiva Pharma, a generics and over-the-counter medicines company that is wholly-owned by private equity firm Advent International and was formerly a subsidiary of Sanofi , has announced a major UK launch. 4 March 2025
Several of the USA’s biggest pharmacy benefit managers (PBMs) have generated billions of dollars in revenue by charging “enormous mark-ups,” according to the competition regulator. 15 January 2025
India's Parliamentary panel has come down heavily on the National Pharmaceutical Pricing Authority (NPPA) and directed it to provide a detailed report explaining the recent 50% price increase on 11 essential drug formulations. 30 December 2024
Exclusive
Company Spotlight
A biopharmaceutical company developing novel therapies for retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).
In Brief
The US affiliate of Teva Pharmaceutical Industries announced today the launch of an authorized generic of Victoza (liraglutide injection 1.8mg), in the USA. 24 June 2024
Mergers and Acquisitions
Global private equity firms Blackstone, Brookfield Corporation and Warburg Pincus are in talks to acquire a majority stake in Hyderabad, India-based Gland Pharma from China's Shanghai Fosun Pharmaceutical in a deal expected to be valued at nearly $3 billion, according to media reports quoting three people with knowledge of the development said. 13 February 2025
17 December 2024
6 December 2024
4 October 2024
5 April 2024
Editor's Pick
Boardroom
Swiss generic and biosimilars drugmaker Sandoz today revealed that Francisco Ballester, president Region International and a member of the Sandoz executive committee, will retire and step down from the SEC on March 1, 2025. 3 February 2025
Going into the second half of 2024, Swiss generics and biosimilars major Sandoz has announcing some senior leadership changes. 8 August 2024
Israeli generics giant Teva Pharmaceutical Industries has appointed Matthew Shields as executive vice president of Teva Global Operations (TGO), the company’s manufacturing and supply division, effective June 3, 2024. 15 May 2024
Israeli generics giant Teva Pharmaceutical Industries has reported its latest quarterly financial results against a backdrop of war in its home region. 8 November 2023